Just as Zach Edey returned, the Memphis Grizzlies face another Ja Morant injury as they continue to sort out issues in the ...
Every good tight end room needs a player like Dulcich. Given his age, prior production, and the flashes he’s shown this ...
The approval was based on data from the single-arm, open-label phase 2 KOMET-001 trial, which evaluated ziftomenib, a menin inhibitor, in adults with R/R AML with an NPM1 mutation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback